The need for new antibacterial drugs to treat the increasing global prevalence of drug-
resistant bacterial infections has clearly attracted global attention, with a range of existing …

The development of new and effective antibacterial drugs to treat multi-drug resistant (MDR)
bacteria, especially Gram-negative (G− ve) pathogens, is acknowledged as one of the …

Increasing resistance to antibiotics worldwide has adverse effects on the effectiveness of
standard therapies to eradicate Helicobacter pylori infection. We reviewed guidelines …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

Helicobacter pylori, a gram-negative microaerophilic pathogen, causes several upper
gastrointestinal diseases, such as chronic gastritis, peptic ulcer disease, and gastric cancer …

Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori
and other gastrointestinal ailments. Combined with antibiotics, these drugs also possess …

The global prevalence of Helicobacter pylori (H. pylori) infection remains high, indicating a
persistent presence of this pathogenic bacterium capable of infecting humans. This review …

Abstract Background and Aims An increase in the use of antibiotics leads to increased
antibiotic resistance of Helicobacter pylori (H pylori). Consequently, it has been considered …

Metal–organic frameworks (MOFs) are favored by researchers on account of their high
surface area, high porosity, excellent structural stability and diverse structures, and have …

Background: There has been a negative trend in the effectiveness of classic eradication
therapy regimens for Helicobacter pylori (H. pylori), which has largely been determined from …